Andrea Bauer Selected Research

Contact Dermatitis (Eczema, Contact)

4/2023	Occupational contact allergy: The European perspective-Analysis of patch test data from ESSCA between 2011 and 2020.
1/2023	Contact sensitizations in massage therapists with occupational contact dermatitis: Patch test data of the Information Network of Departments of Dermatology, 2008-2020.
5/2022	European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC.
1/2022	German S1 guideline: Contact dermatitis.
3/2021	European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.
3/2015	Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe - analyses of the European Surveillance System on Contact Allergy network, 2002-2010.
3/2015	Occupational contact allergy in nurses: results from the Information Network of Departments of Dermatology 2003-2012.
10/2013	Contact dermatitis in the cleaning industry.
8/2005	Contact dermatitis to quinoline, corticosteroids and antibiotics after short time treatment of delayed wound healing following malignant melanoma excision in a young woman.
5/2002	Patch tests with thiurams at 0.25% pet. and 1% pet. are of equal diagnostic value.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Bauer Research Topics

Disease

25	Hypersensitivity (Allergy) 12/2023 - 09/2011
16	Dermatitis 01/2024 - 02/2002
15	Neoplasms (Cancer) 08/2015 - 01/2004
10	Contact Dermatitis (Eczema, Contact) 04/2023 - 05/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 03/2020 - 03/2007
9	Chronic Urticaria 02/2024 - 01/2017
9	Atopic Dermatitis (Atopic Eczema) 01/2024 - 12/2004
8	Eczema 04/2024 - 08/2010
7	Anaphylaxis (Anaphylactic Shock) 01/2023 - 07/2014
5	Urticaria (Hives) 02/2024 - 10/2019
4	Angioedema 02/2024 - 01/2020
4	COVID-19 11/2023 - 01/2021
4	Allergic Contact Dermatitis 01/2023 - 10/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 12/2020 - 10/2009
3	Occupational Dermatitis 01/2023 - 09/2011
2	Wounds and Injuries (Trauma) 10/2023 - 07/2020
2	Pain (Aches) 07/2023 - 01/2022
2	Bites and Stings (Sting) 01/2023 - 01/2020
2	Cold Urticaria 01/2022 - 01/2022
2	Skin Neoplasms (Skin Cancer) 01/2021 - 08/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2019 - 04/2015
2	Melanoma (Melanoma, Malignant) 10/2018 - 08/2005
2	Heart Failure 10/2017 - 03/2013
2	Adenocarcinoma 08/2015 - 06/2007
2	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 03/2007
2	Atherosclerosis 03/2010 - 07/2008
1	Chronic Inducible Urticaria 02/2024
1	Stomatitis 12/2023
1	Autoimmune Diseases (Autoimmune Disease) 11/2023
1	Fever (Fevers) 11/2023
1	Fatigue 11/2023
1	Myalgia 11/2023
1	Mental Disorders (Mental Disorder) 11/2023
1	Pruritus (Itching) 03/2023
1	Mastocytosis 01/2023
1	Immediate Hypersensitivity 11/2022
1	Unconsciousness (Loss of Consciousness) 01/2022
1	Nasopharyngitis 01/2022
1	Headache (Headaches) 01/2022

Drug/Important Bio-Agent (IBA)

16	AllergensIBA 04/2024 - 09/2011
9	Omalizumab (Xolair)FDA Link 11/2023 - 01/2017
9	Irritants (Vesicants)IBA 07/2022 - 05/2002
8	Proteins (Proteins, Gene)FDA Link 03/2020 - 03/2007
6	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 01/2020
4	VaccinesIBA 11/2023 - 01/2021
4	Formaldehyde (Formol)FDA Link 02/2021 - 09/2011
4	DNA (Deoxyribonucleic Acid)IBA 02/2015 - 01/2004
3	Epoxy Resins FDA Link 04/2024 - 03/2015
3	Immunoglobulin A (IgA)IBA 03/2023 - 06/2012
3	Tryptases (Tryptase)IBA 01/2023 - 01/2020
3	anti-IgE antibodiesIBA 01/2023 - 01/2017
3	Messenger RNA (mRNA)IBA 11/2022 - 03/2007
3	Histamine Antagonists (Antihistamines)IBA 01/2021 - 01/2019
3	Thiram FDA Link 11/2015 - 05/2002
2	AcrylatesIBA 04/2024 - 12/2023
2	Peruvian balsam (balsam of Peru)IBA 12/2023 - 02/2021
2	NickelIBA 12/2023 - 02/2021
2	COVID-19 VaccinesIBA 11/2023 - 11/2022
2	Volatile Oils (Essential Oils)IBA 08/2023 - 01/2023
2	delgocitinibIBA 07/2023 - 01/2022
2	dupilumabIBA 03/2023 - 09/2022
2	Arthropod VenomsIBA 01/2023 - 01/2020
2	Immunoglobulin E (IgE)IBA 01/2023 - 04/2018
2	VenomsIBA 01/2023 - 01/2021
2	2-methyl-4-isothiazolin-3-oneIBA 02/2021 - 03/2015
2	HaptensIBA 02/2021 - 06/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2021
2	CosmeticsIBA 03/2020 - 10/2013
2	ProteomeIBA 01/2018 - 06/2012
2	AntigensIBA 01/2018 - 03/2013
2	Detergents (Detergent)IBA 01/2018 - 02/2010
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2015 - 10/2012
2	Heme (Haem)IBA 06/2015 - 03/2010
2	Formoterol Fumarate (Oxis)FDA Link 11/2009 - 10/2009
2	Small Interfering RNA (siRNA)IBA 01/2009 - 03/2007
1	acrylic acid (acrylate)IBA 04/2024
1	Cholinergic Agents (Cholinergics)IBA 02/2024
1	Prostaglandins AIBA 02/2024
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2024
1	Histamine Receptors (Histamine Receptor)IBA 02/2024
1	Propolis (Bee Bread)IBA 12/2023
1	Dental MaterialsIBA 12/2023
1	PalladiumIBA 12/2023
1	hydroxyethyl methacrylate (HEMA)IBA 12/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2023
1	Bee Venoms (Bee Venom)IBA 01/2023
1	mRNA VaccinesIBA 11/2022
1	Janus Kinase InhibitorsIBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2024 - 06/2012
3	Drug Therapy (Chemotherapy) 01/2024 - 08/2015
3	Nebulizers and Vaporizers (Inhaler) 12/2020 - 11/2009
2	Skin Care 04/2024 - 02/2002
2	Cesarean Section (Caesarean Section) 10/2023 - 07/2020
2	Tattooing 01/2022 - 10/2018
1	Orthodontics 04/2024
1	Complementary Therapies (Alternative Medicine) 01/2024
1	Off-Label Use 01/2023
1	Massage (Zone Therapy) 01/2023
1	Operative Surgical Procedures 01/2022